| UniProt ID | PFD3_HUMAN | |
|---|---|---|
| UniProt AC | P61758 | |
| Protein Name | Prefoldin subunit 3 | |
| Gene Name | VBP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 197 | |
| Subcellular Localization | Cytoplasm. Nucleus. In complex with VHL can translocate to the nucleus. | |
| Protein Description | Binds specifically to cytosolic chaperonin (c-CPN) and transfers target proteins to it. Binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins.. | |
| Protein Sequence | MAAVKDSCGKGEMATGNGRRLHLGIPEAVFVEDVDSFMKQPGNETADTVLKKLDEQYQKYKFMELNLAQKKRRLKGQIPEIKQTLEILKYMQKKKESTNSMETRFLLADNLYCKASVPPTDKMCLWLGANVMLEYDIDEAQALLEKNLSTATKNLDSLEEDLDFLRDQFTTTEVNMARVYNWDVKRRNKDDSTKNKA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAVKDSCG ------CCCCCCCCC | 22.44 | 22814378 | |
| 5 | Acetylation | ---MAAVKDSCGKGE ---CCCCCCCCCCCC | 38.92 | 23749302 | |
| 5 | Ubiquitination | ---MAAVKDSCGKGE ---CCCCCCCCCCCC | 38.92 | - | |
| 7 | Phosphorylation | -MAAVKDSCGKGEMA -CCCCCCCCCCCCCC | 21.03 | 25159151 | |
| 10 | Ubiquitination | AVKDSCGKGEMATGN CCCCCCCCCCCCCCC | 56.90 | - | |
| 10 | Acetylation | AVKDSCGKGEMATGN CCCCCCCCCCCCCCC | 56.90 | 26051181 | |
| 39 | Ubiquitination | EDVDSFMKQPGNETA ECHHHHHCCCCCCCH | 51.86 | - | |
| 51 | Ubiquitination | ETADTVLKKLDEQYQ CCHHHHHHHHHHHHH | 47.13 | - | |
| 51 | Acetylation | ETADTVLKKLDEQYQ CCHHHHHHHHHHHHH | 47.13 | 25953088 | |
| 52 | Ubiquitination | TADTVLKKLDEQYQK CHHHHHHHHHHHHHH | 57.94 | - | |
| 54 | Ubiquitination | DTVLKKLDEQYQKYK HHHHHHHHHHHHHHH | 50.24 | - | |
| 54 | Acetylation | DTVLKKLDEQYQKYK HHHHHHHHHHHHHHH | 50.24 | - | |
| 56 | Ubiquitination | VLKKLDEQYQKYKFM HHHHHHHHHHHHHHH | 45.70 | - | |
| 59 | Ubiquitination | KLDEQYQKYKFMELN HHHHHHHHHHHHHHH | 45.53 | 21890473 | |
| 59 | Acetylation | KLDEQYQKYKFMELN HHHHHHHHHHHHHHH | 45.53 | 19608861 | |
| 60 | Phosphorylation | LDEQYQKYKFMELNL HHHHHHHHHHHHHHH | 8.24 | - | |
| 61 | Ubiquitination | DEQYQKYKFMELNLA HHHHHHHHHHHHHHH | 45.32 | 21890473 | |
| 61 | Acetylation | DEQYQKYKFMELNLA HHHHHHHHHHHHHHH | 45.32 | 27452117 | |
| 63 | Sulfoxidation | QYQKYKFMELNLAQK HHHHHHHHHHHHHHH | 5.11 | 21406390 | |
| 65 | Ubiquitination | QKYKFMELNLAQKKR HHHHHHHHHHHHHHH | 4.23 | - | |
| 66 | Ubiquitination | KYKFMELNLAQKKRR HHHHHHHHHHHHHHH | 21.74 | - | |
| 70 | Acetylation | MELNLAQKKRRLKGQ HHHHHHHHHHHHCCC | 42.51 | 25953088 | |
| 70 | Ubiquitination | MELNLAQKKRRLKGQ HHHHHHHHHHHHCCC | 42.51 | 21890473 | |
| 71 | Ubiquitination | ELNLAQKKRRLKGQI HHHHHHHHHHHCCCC | 30.58 | - | |
| 75 | Ubiquitination | AQKKRRLKGQIPEIK HHHHHHHCCCCHHHH | 47.13 | - | |
| 77 | Ubiquitination | KKRRLKGQIPEIKQT HHHHHCCCCHHHHHH | 46.61 | - | |
| 82 | Ubiquitination | KGQIPEIKQTLEILK CCCCHHHHHHHHHHH | 35.25 | 21890473 | |
| 84 | Ubiquitination | QIPEIKQTLEILKYM CCHHHHHHHHHHHHH | 22.74 | - | |
| 89 | Ubiquitination | KQTLEILKYMQKKKE HHHHHHHHHHHHHCC | 44.32 | 21890473 | |
| 95 | Ubiquitination | LKYMQKKKESTNSME HHHHHHHCCCCCCHH | 65.02 | 21890473 | |
| 97 | Ubiquitination | YMQKKKESTNSMETR HHHHHCCCCCCHHHH | 41.59 | 21890473 | |
| 97 | Phosphorylation | YMQKKKESTNSMETR HHHHHCCCCCCHHHH | 41.59 | 20068231 | |
| 98 | Phosphorylation | MQKKKESTNSMETRF HHHHCCCCCCHHHHH | 32.19 | 20068231 | |
| 100 | Phosphorylation | KKKESTNSMETRFLL HHCCCCCCHHHHHHH | 20.34 | 25954137 | |
| 103 | Phosphorylation | ESTNSMETRFLLADN CCCCCHHHHHHHCCC | 20.34 | 20068231 | |
| 106 | Ubiquitination | NSMETRFLLADNLYC CCHHHHHHHCCCEEE | 3.29 | 21890473 | |
| 112 | Phosphorylation | FLLADNLYCKASVPP HHHCCCEEECCCCCC | 9.73 | 28796482 | |
| 113 | Glutathionylation | LLADNLYCKASVPPT HHCCCEEECCCCCCC | 3.15 | 22555962 | |
| 113 | S-nitrosylation | LLADNLYCKASVPPT HHCCCEEECCCCCCC | 3.15 | 19483679 | |
| 113 | S-nitrosocysteine | LLADNLYCKASVPPT HHCCCEEECCCCCCC | 3.15 | - | |
| 114 | Ubiquitination | LADNLYCKASVPPTD HCCCEEECCCCCCCC | 30.09 | - | |
| 118 | Ubiquitination | LYCKASVPPTDKMCL EEECCCCCCCCCCEE | 24.47 | 21890473 | |
| 125 | Ubiquitination | PPTDKMCLWLGANVM CCCCCCEEEECCCEE | 3.65 | 21890473 | |
| 148 | Ubiquitination | QALLEKNLSTATKNL HHHHHHCHHHHHHCH | 7.73 | - | |
| 153 | Ubiquitination | KNLSTATKNLDSLEE HCHHHHHHCHHHHHH | 53.72 | 21906983 | |
| 157 | Phosphorylation | TATKNLDSLEEDLDF HHHHCHHHHHHHHHH | 40.63 | 20873877 | |
| 170 | Phosphorylation | DFLRDQFTTTEVNMA HHHHHHCCCCHHHHH | 27.46 | 25022875 | |
| 176 | Sulfoxidation | FTTTEVNMARVYNWD CCCCHHHHHHHCCCC | 2.81 | 21406390 | |
| 180 | Ubiquitination | EVNMARVYNWDVKRR HHHHHHHCCCCCCCC | 12.65 | - | |
| 185 | Ubiquitination | RVYNWDVKRRNKDDS HHCCCCCCCCCCCCC | 43.07 | 21890473 | |
| 185 | Acetylation | RVYNWDVKRRNKDDS HHCCCCCCCCCCCCC | 43.07 | 25953088 | |
| 189 | Ubiquitination | WDVKRRNKDDSTKNK CCCCCCCCCCCCCCC | 62.19 | 21890473 | |
| 221 | Ubiquitination | ------------------------------- ------------------------------- | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PFD3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PFD3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PFD3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-59, AND MASS SPECTROMETRY. | |